Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT06411379. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study to evaluate the clinical efficacy and safety of sonelokimab administered subcutaneously compared with placebo in the treatment of adult participants with moderate to severe hidradenitis suppurativa. Participants will be randomized 2:1 to either sonelokimab or matching placebo up to Week 16.
Study identification
- NCT ID
- NCT06411379
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 418 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 14, 2024 (Actual)
- Primary completion
- Aug 14, 2025 (Actual)
- Completion
- May 20, 2026 (Actual)
- Last update posted
- Jun 8, 2026
2024 – 2026
United States locations
- U.S. sites
- 30
- U.S. states
- 20
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Site | Birmingham | Alabama | 35244 | — |
| Clinical Site | North Little Rock | Arkansas | 72117 | — |
| Clinical Site | Fountain Valley | California | 92708 | — |
| Clinical Site | Santa Monica | California | 90404 | — |
| Clinical Site | Aventura | Florida | 33180 | — |
| Clinical Site | Hialeah | Florida | 33012 | — |
| Clinical Site | Miami | Florida | 33136 | — |
| Clinical Site | Ocala | Florida | 34470 | — |
| Clinical Site | Tampa | Florida | 33613 | — |
| Clinical Site | Skokie | Illinois | 60077 | — |
| Clinical Site | Plainfield | Indiana | 46168 | — |
| Clinical Site | Murray | Kentucky | 42071 | — |
| Clinical Site | Baton Rouge | Louisiana | 70809 | — |
| Clinical Site | Baltimore | Maryland | 21287 | — |
| Clinical Site | Ann Arbor | Michigan | 48109-5314 | — |
| Clinical Site | Canton | Michigan | 48187 | — |
| Clinical Site | Clarkston | Michigan | 48346 | — |
| Clinical Site | Waterford | Michigan | 48328 | — |
| Clinical Site | New Brighton | Minnesota | 55112 | — |
| Clinical Site | Omaha | Nebraska | 68144 | — |
| Clinical Site | Las Vegas | Nevada | 89145 | — |
| Clinical Site | New York | New York | 10003 | — |
| Clinical Site | Fargo | North Dakota | 58103 | — |
| Clinical Site | Columbus | Ohio | 43213 | — |
| Clinical Site | Murfreesboro | Tennessee | 37130 | — |
| Clinical Site | Dallas | Texas | 75390-8565 | — |
| Clinical Site | Plano | Texas | 75025 | — |
| Clinical Site | San Antonio | Texas | 78213 | — |
| Clinical Site | Morgantown | West Virginia | 26505 | — |
| Clinical Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 76 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06411379, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2026 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06411379 live on ClinicalTrials.gov.